Clinical Trial Update: Avastin for CNV Secondary to Pattern Dystrophy [Phase 2, Phase 3]

View source ↗

Summary

This update reports on ongoing Phase 2/Phase 3 trials evaluating Avastin (bevacizumab) for choroidal neovascularization secondary to pattern dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Pattern Dystrophy of the Retina

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Trieste | Conditions: Choroidal Neovascularization Secondary to Pattern Dystrophy | Phase 2, Phase 3 | Status: UNKNOWN